---
figid: PMC7485347__ONCO-25-738-g004
figtitle: Tazemetostat in SMARCB1/INI‐1–deficiency
organisms:
- Homo sapiens
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC7485347
filename: ONCO-25-738-g004.jpg
figlink: pmc/articles/PMC7485347/figure/onco13335-fig-0004/
number: F4
caption: 'Mechanism of Tazemetostat in SMARCB1/INI‐1–deficiency. (A): SMARCB1 within
  the SWI/SNF complex inhibits PRC2/EZH2 function. This leads to histone H3K27 methylation
  inhibition and expression of cell cycle suppressor genes including p16 and decreased
  activity of cell cycle promoter genes (e.g., cyclin D1). (B): SMARCB1 inactivation
  leads to histone methylation and tumor suppressor gene downregulation, Tazemetostat
  (EPZ‐6438) is a selective oral inhibitor of EZH2. EZH2 inhibits the downstream pathway
  similar to SMARCB1.Abbreviations: PRC2, polycomb protein; SWI/SNF, SWItch/Sucrose
  Nonfermentable.'
papertitle: 'INI‐1 (SMARCB1)–Deficient Undifferentiated Sinonasal Carcinoma: Novel
  Paradigm of Molecular Testing in the Diagnosis and Management of Sinonasal Malignancies.'
reftext: Khvaramze Shaverdashvili, et al. Oncologist. 2020 Sep;25(9):738-744.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.916889
figid_alias: PMC7485347__F4
figtype: Figure
redirect_from: /figures/PMC7485347__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7485347__ONCO-25-738-g004.html
  '@type': Dataset
  description: 'Mechanism of Tazemetostat in SMARCB1/INI‐1–deficiency. (A): SMARCB1
    within the SWI/SNF complex inhibits PRC2/EZH2 function. This leads to histone
    H3K27 methylation inhibition and expression of cell cycle suppressor genes including
    p16 and decreased activity of cell cycle promoter genes (e.g., cyclin D1). (B):
    SMARCB1 inactivation leads to histone methylation and tumor suppressor gene downregulation,
    Tazemetostat (EPZ‐6438) is a selective oral inhibitor of EZH2. EZH2 inhibits the
    downstream pathway similar to SMARCB1.Abbreviations: PRC2, polycomb protein; SWI/SNF,
    SWItch/Sucrose Nonfermentable.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SMARCB1
  - SMARCA1
  - EED
  - EZH1
  - EZH2
  - SUZ12
  - H1-0
  - H1-1
  - H1-2
  - H1-3
  - H1-4
  - H1-5
  - H1-6
  - H1-7
  - H1-8
  - H1-10
  - .na.character
  - H2AB1
  - H2AJ
  - H2AZ2
  - H2AX
  - MACROH2A1
  - MACROH2A2
  - H2AZ1
  - H2AC1
  - H2AC6
  - H2AC7
  - H2AC12
  - H2AC14
  - H2AC21
  - H2AC20
  - H2AC25
  - H2BC1
  - H2BC3
  - H2BC5
  - H2BC9
  - H2BC11
  - H2BC12
  - H2BC13
  - H2BC14
  - H2BC15
  - H2BC17
  - H2BC18
  - H2BC19P
  - H2BC20P
  - H2BC21
  - H2BC26
  - H2BC12L
  - H2BW2
  - H2BW1
  - H3-4
  - H3-5
  - H4C7
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - TMEM115
  - CDKN2A
  - H3P10
  - SERPINB6
  - snf
  - hfw
  - Iswi
  - E(z)
  - Me
  - ac
  - CycE
  - cyc
  - Zdhhc8
  - Arpc5
  - Su(osk)P16
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - EPZ-6438
  - Me  Me  Me  Ac
  - Ac
---
